PepGen Inc. (PEPG) — insider trading
Health Care · NASDAQ
PepGen Inc. (PEPG) has 15 reported SEC Form 4 insider transactions in our data, including 7 open-market sales among the most recent 15 (latest 2026-06-18).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | KEATING LAURIE | Director | Grant / award / vesting (derivative) | 34,000 | — | $0 | Form 4 |
| 2026-06-18 | HENSON HEIDI | Director | Grant / award / vesting (derivative) | 34,000 | — | $0 | Form 4 |
| 2026-06-18 | Dable Habib J | Director | Grant / award / vesting (derivative) | 34,000 | — | $0 | Form 4 |
| 2026-06-18 | Finer Mitchell H. | Director | Grant / award / vesting (derivative) | 34,000 | — | $0 | Form 4 |
| 2026-06-18 | Mayer Howard | Director | Grant / award / vesting (derivative) | 34,000 | — | $0 | Form 4 |
| 2026-06-18 | Resnick Joshua | Director | Grant / award / vesting (derivative) | 34,000 | — | $0 | Form 4 |
| 2026-06-18 | Wyman Lisa | Director | Grant / award / vesting (derivative) | 34,000 | — | $0 | Form 4 |
| 2026-06-18 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Kolchinsky Peter; Shah Rajeev M. | Director, 10% owner | Grant / award / vesting (derivative) | 34,000 | — | $0 | Form 4 |
| 2026-05-21 | Kasraian Kasra | Officer (Chief Technical Officer) | Open-market sale | 1,233 | $1.41 | $1.7K | Form 4 |
| 2026-03-04 | McArthur James G | Director, Officer (President and CEO) | Open-market sale | 131 | $6.33 | $829 | Form 4 |
| 2026-03-04 | McArthur James G | Director, Officer (President and CEO) | Open-market sale | 5,144 | $6.23 | $32.0K | Form 4 |
| 2026-03-04 | Donnelly Noel | Officer (Chief Financial Officer) | Open-market sale | 52 | $6.33 | $329 | Form 4 |
| 2026-03-04 | Donnelly Noel | Officer (Chief Financial Officer) | Open-market sale | 2,032 | $6.23 | $12.7K | Form 4 |
| 2026-03-04 | STRECK PAUL | Officer (EVP, Head of R&D) | Open-market sale | 47 | $6.29 | $296 | Form 4 |
| 2026-03-04 | STRECK PAUL | Officer (EVP, Head of R&D) | Open-market sale | 1,832 | $6.23 | $11.4K | Form 4 |
Ask the chat about PEPG's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: PepGen Inc. (PEPG).
Last updated 2026-06-18 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.